Virax Biolabs (VRAX) has finalized a distribution agreement with a supplier of RT-PCR Mpox virus detection kits to market these kits across 13 European countries and the Gulf Cooperation Council (GCC) members, which include Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.Under this agreement, Virax is authorized to import, sell, and distribute Virax-branded Mpox Virus Nucleic Acid Detection Kits in European countries such as the United Kingdom, France, Portugal, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Spain, Switzerland, and Austria, as well as in the GCC nations.On the news of this agreement, shares of Virax Biolabs saw a 23% increase in pre-market trading on Wednesday.The material has been provided by InstaForex Company – www.instaforex.com
- Air Canada And ALPA Reach Tentative Four-Year Agreement - September 15, 2024
- J&J’s TAR-200 Phase 2b SunRISe-1 Study Shows 84% Complete Response In High-Risk Bladder Cancer - September 15, 2024
- Saudi Arabia’s CPI Holds Steady at 0.1% for August, Defying Market Expectations - September 15, 2024
